NCM
CVS icon

Narwhal Capital Management’s CVS Health CVS Stock Holding History

Narwhal Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$688K Buy
6,646
+2,510
+61% +$224K 0.05% 112
2026
Q1 		$297K Hold
4,136
– – 0.02% 150
2025
Q4 		$328K Hold
4,136
– – 0.02% 139
2025
Q3 		$312K Sell
4,136
-383
-8% -$26.2K 0.02% 143
2025
Q2 		$312K Sell
4,519
-6,750
-60% -$443K 0.03% 143
2025
Q1 		$763K Sell
11,269
-240
-2% -$14.4K 0.07% 114
2024
Q4 		$517K Sell
11,509
-15,585
-58% -$874K 0.05% 127
2024
Q3 		$1.7M Sell
27,094
-9,358
-26% -$546K 0.15% 84
2024
Q2 		$2.15M Sell
36,452
-2,127
-6% -$133K 0.2% 78
2024
Q1 		$3.08M Sell
38,579
-14,013
-27% -$1.07M 0.3% 69
2023
Q4 		$4.15M Sell
52,592
-6,521
-11% -$464K 0.45% 58
2023
Q3 		$4.13M Sell
59,113
-19
-0% -$1.35K 0.5% 53
2023
Q2 		$4.09M Buy
59,132
+10,905
+23% +$776K 0.48% 56
2023
Q1 		$3.58M Sell
48,227
-963
-2% -$80.8K 0.45% 58
2022
Q4 		$4.58M Buy
49,190
+4,997
+11% +$482K 0.61% 46
2022
Q3 		$4.21M Buy
44,193
+2,730
+7% +$270K 0.61% 49
2022
Q2 		$3.84M Buy
41,463
+54
+0.1% +$5.27K 0.53% 52
2022
Q1 		$4.19M Sell
41,409
-9,236
-18% -$970K 0.49% 55
2021
Q4 		$5.22M Buy
50,645
+293
+0.6% +$27.1K 0.59% 47
2021
Q3 		$4.27M Buy
50,352
+29
+0.1% +$2.43K 0.54% 51
2021
Q2 		$4.2M Buy
50,323
+1,255
+3% +$103K 0.53% 53
2021
Q1 		$3.69M Sell
49,068
-1,569
-3% -$114K 0.5% 52
2020
Q4 		$3.46M Sell
50,637
-19,286
-28% -$1.25M 0.49% 56
2020
Q3 		$4.08M Buy
69,923
+7,772
+13% +$484K 0.66% 48
2020
Q2 		$4.04M Sell
62,151
-2,485
-4% -$156K 0.7% 46
2020
Q1 		$3.83M Buy
64,636
+13,999
+28% +$935K 0.83% 43
2019
Q4 		$3.76M Sell
50,637
-735
-1% -$51.6K 0.69% 48
2019
Q3 		$3.24M Sell
51,372
-15,380
-23% -$911K 0.65% 49
2019
Q2 		$3.64M Sell
66,752
-2,534
-4% -$136K 0.75% 43
2019
Q1 		$3.74M Buy
69,286
+23,841
+52% +$1.47M 0.81% 40
2018
Q4 		$2.98M Buy
45,445
+17,835
+65% +$1.33M 0.74% 47
2018
Q3 		$2.17M Buy
27,610
+450
+2% +$32.2K 0.48% 69
2018
Q2 		$1.75M Buy
27,160
+9,848
+57% +$649K 0.41% 79
2018
Q1 		$1.08M Buy
17,312
+12,312
+246% +$883K 0.25% 100
2017
Q4 		$363K Sell
5,000
-25,565
-84% -$1.86M 0.08% 128
2017
Q3 		$2.49M Sell
30,565
-1,505
-5% -$119K 0.62% 56
2017
Q2 		$2.58M Buy
32,070
+15,780
+97% +$1.25M 0.67% 53
2017
Q1 		$1.28M Buy
+16,290
New +$1.3M 0.36% 84

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Narwhal Capital Management's CVS Position: Q2 2026 in Review

Narwhal Capital Management increased its CVS Health (CVS) stake by 61% in Q2 2026, buying an estimated $224K and bringing the position to 6,646 shares worth $688K. The position accounts for 0.05% of the portfolio, ranked #112.

Narwhal Capital Management first reported a position in CVS in Q1 2017 and has held it in 38 quarters since. The position peaked at $5.22M in Q4 2021. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Narwhal Capital Management held 6,646 shares of CVS Health worth $688K as of Q2 2026.
  • Narwhal Capital Management bought 2,510 CVS Health shares in Q2 2026, an estimated $224K.
  • CVS Health made up 0.05% of Narwhal Capital Management's portfolio in Q2 2026, its #112 holding.
  • Narwhal Capital Management first reported a position in CVS Health in Q1 2017 and has held it in 38 quarters since.
  • Narwhal Capital Management's CVS Health position peaked at $5.22M in Q4 2021.
  • 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Narwhal Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.